Optimizing gastric cancer treatment: the role of LODDs in lymph node staging
-
By
-
Zhao Hao
-
Haiyan Niu
-
Yuebo Bi
-
Qimin Sun
-
Wenjun Yang
-
June 9, 2026
-
Clinical Scorecard: Enhancing Treatment Strategies for Gastric Cancer: The Importance of LODDs in Lymph Node Assessment
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Log odds of positive lymph nodes (LODDs), AJCC N stage, lymph node ratio (LNR), and their comparative prognostic value. |
| Target Population | |
| Care Setting | |
Key Highlights
- Gastric cancer has a high incidence and mortality rate worldwide.
- Accurate lymph node staging is crucial for optimizing treatment strategies.
- LODDs showed better prognostic performance compared to AJCC-N and LNR.
- A nomogram based on LODDs can aid in individualized prognostic assessment.
- Higher examined lymph node counts correlate with improved survival outcomes.
- Incorporating LODDs into treatment planning enhances patient outcomes.
Guideline-Based Recommendations
Diagnosis
Management
- Consider the number of examined lymph nodes in treatment planning.
- Tailor treatment strategies based on LODDs results.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients undergoing gastrectomy for gastric adenocarcinoma
Adequate lymph node evaluation is critical for accurate staging and prognosis.
Clinical Best Practices
- Aim for a minimum of 17 examined lymph nodes; optimal is 33 for accurate staging, as higher counts improve prognostic accuracy.
- Incorporate LODDs into prognostic assessments for better survival predictions.
Related Resources & Content
